Goodwin Biotechnology Inc. (GBI) Announces First Commercial Contract Signing

About GBI About GBI GBI is a uniquely qualified and flexible US–based CDMO (contract development and manufacturing organization) that offers a Single Source Solution ™to enhance the value of complex biopharmaceuticals for our clients. With 30 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies and institutions of all sizes, taking their products through clinical trials and towards rapid commercialization. GBI provides process...

PLANTATION, Fla., 04/04/2023 (informazione.it - comunicati stampa - salute e benessere)

About GBI

GBI is a uniquely qualified and flexible US–based CDMO (contract development and manufacturing organization) that offers a Single Source Solution to enhance the value of complex biopharmaceuticals for our clients. With 30 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies and institutions of all sizes, taking their products through clinical trials and towards rapid commercialization. GBI provides process development and cGMP manufacturing services encompassing drug substances and drug products for complex biologics, including multi-specific antibodies, recombinant proteins, antibody-drug conjugates, and other cell-based products.

For more information, please visit https://www.gbibio.com/

or

Contact: info@gbibio.com

GBI
1850 N.W. 69th Avenue
Plantation, FL 33313
Phone: 954-321-5300
Fax: 954-587-6378
info@gbibio.com 

Logo - https://mma.prnewswire.com/media/1965652/gbi_logo_rgb_Logo.jpg 

View original content:https://www.prnewswire.com/news-releases/goodwin-biotechnology-inc-gbi-announces-first-commercial-contract-signing-301787830.html